Autres langues Recce Pharmaceuticals Ltd

Actions

RCE

AU000000RCE5

Produits pharmaceutiques

Marché Fermé - Australian S.E. 07:54:51 28/08/2026			Varia. 5j.	Varia. 1 janv.
0,3675 ^AUD	-2,00%		-4,55%	-43,46%

19/08	Recce Pharmaceuticals reçoit le feu vert éthique pour un nouveau bras d'étude dans son essai de phase 3 sur le traitement des infections du pied diabétique	MT
30/07	Recce Pharmaceuticals en position de force face à la nouvelle stratégie de contre-mesures médicales de l'ASPR aux États-Unis	MT

Autres langues

19/08	Recce Pharmaceuticals Gets Ethics Approval for New Study Arm in Phase 3 Trial of Diabetic Foot Infection Treatment
30/07	Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy
21/07	Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter
20/07	Recce Pharmaceuticals Extends Share Purchase Plan Closing Date
14/07	ASX Preview: Australian Shares to Decline; Genesis Minerals to Acquire Vault Minerals for AU$5.274 per Share
14/07	Recce Pharmaceuticals Secures Family 4 Patent for Anti-Infectives in Vietnam
26/06	Recce Pharmaceuticals to Raise AU$4 million via Share Placement; Shares Down 17%
24/06	Recce Pharmaceuticals Requests Trading Halt Ahead of Equity Raise
22/06	Recce Says HREC Approval Progresses Phase 3 Clinical Trial of Diabetic Foot Infections Treatment Candidate
27/05	Recce Pharmaceuticals Enters Proposed 10-Year Exclusive Licensing Nonbinding Agreement with Middle Eastern Firm, Shares Rise 10%
27/05	Recce Pharmaceuticals signs Middle East licensing term sheet
21/04	Recce Pharmaceuticals Says Indonesian Regulator Completes Routine Regulatory Inspection of Phase Three Clinical Trial Site
24/03	Recce Pharmaceuticals Secures Brazilian Family 4 Patent For Anti-Infectives
27/02	Recce Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended December 31, 2025
02/02	Australian Shares Fall; GrainCorp Sees Sharp Earnings Decline in Fiscal 2026
02/02	Recce Pharmaceuticals enters second U.S. Department of Defense research and development agreement
02/02	Recce Pharmaceuticals Enters Into Research Agreement With US Army Institute of Surgical Research
14/01	Recce Pharmaceuticals Ltd Receives AUD 5.3 Million R&D Rebate
16/12	Recce Pharmaceuticals Receives Up to AU$85 Million in Research, Development Finding; Shares Up 3%
16/12	Recce Pharmaceuticals awarded AusIndustry advanced overseas finding for up to A$85M
15/12	Recce Pharmaceuticals Limited Receives Advanced Overseas Finding up to AUD 85 Million
27/11	Recce Pharmaceuticals Secures Family 4 Patent for Anti-Infectives in Hong Kong, Shares Jump 6%
26/11	Recce Pharmaceuticals Says Hospital/Ventilator-Acquired Pneumonia Study in Mice Shows Antibacterial Activity of R327 Therapy Candidate
14/11	Recce Pharmaceuticals Ltd Announces Passing of Founder Graham Melrose
05/11	Recce Receives 'First Strike' Against Remuneration Report; Shares Up 3%